The prevalence of helicobacter pylori-antibody in hemodialysis and capd patients

İn this study, the prevalence of H.pylori-lgG antibody was investigated in 83 hemodialysis (HD) and 30 CAPD patients and compared with those of 45 healthy control group. İn determination of IgG antibody against H.pylori enzyme immunoassay ELİSA method was used. Mean ages were 46.2+17.4 and 44.6+15.7 years and dialysis durations were 35.4+ 36.9 months and 20.2+18 months in HD and CAPD patients respectively. Age of control group was 49.4+15.3 (18-80) years. H. Pylori-antibody was positive in 36 HD patients (43.4 %), in 9 CAPD patients (30 %) and in 19 healthy Controls (42.2 %). Hp-lgG antibody positivity in HD and CAPD patients was not statistically different from control subjects. İn conclusion, there is no assosiation between Hp-lgG antibody posi­ tivity and age, sex, dyspeptic symptoms two groups. İn this patients Hp IgG positivity should not be evaluated with- out endoscopic and.histopathologic findings.